The OSSIOfiber^® Interference Screws, are indicated for fixation of tissue, including ligament or tendon to bone, or a bone/tendon to bone in adults and children (2–12 years) and adolescents (12–21 years) in which growth plates have fused or in which growth plates will not be crossed by fixation. Interference fixation is appropriate for surgeries of the knee, shoulder, elbow, ankle, foot, and hand/wrist where the sizes offered are patient appropriate; Specifically: Shoulder Rotator Cuff Repairs, Bankart Repair, SLAP Lesion Repair, Biceps Tenodesis, Acromio-Clavicular Separation Repair, Deltoid Repair, Capsular Shift or Capsulolabral Reconstruction. Foot/Ankle Lateral Stabilization, Medial Stabilization, Achilles Tendon Repair, Hallux Valgus Reconstruction, Midfoot Reconstruction, Metatarsal Ligament Repair, Flexor Hallucis Longus for Achilles Tendon reconstruction, tendon transfers in the foot and ankle. Knee Repair/Reconstruction of the Anterior Cruciate Ligament, Posterior Cruciate Ligament, Medial Collateral Ligament, Lateral Collateral Ligament, Patellar Tendon, Posterior Oblique Ligament, Iliotibial Band Tenodesis, MPFL. Elbow Biceps Tendon Reattachment, Ulnar or Radial Collateral Ligament Reconstruction. Hand/Wrist Scapholunate Ligament Reconstruction, Ulnar Collateral Ligament Reconstruction, Radial Collateral Ligament Reconstruction, Carpometacarpal joint arthroplasty (basal thumb joint arthroplasty), Carpal Ligament Reconstructions and repairs, tendon transfer in the hand/wrist. Refer to the product Instructions for Use for complete warnings, precautions, indications, contraindications, and technique.

Yes, the OSSIOfiber^® Interference Screw is covered under existing reimbursement codes in the US for common orthopedic procedures. Please contact OSSIO for more information.

OSSIOfiber^® is 5x stronger than conventional bio-resorbables and contributes to early bone attachment and subsequent bone integration. Findings from a 2-year preclinical study comparing OSSIOfiber^® to conventional bio-resorbables showed that unlike conventional bio-resorbables, OSSIOfiber^® integrates in a gradual and predictable way, with no adverse inflammation observed. Please refer to the “Science Behind OSSIOfiber^®” page of this website for more detailed information. *Data on file at OSSIO

The OSSIOfiber^® bio-integration process begins shortly after surgery and continues in a gentle, gradual, and predictable way until it is completely incorporated into the surrounding anatomy in roughly 78-104 weeks, as proven in pre-clinical studies. After full bio-integration, the implant is completely gone and replaced by healthy bone. Bone attachment is seen in as little as 2 weeks post surgery, followed by incorporation and ultimate replacement of the implant by tissue – a process that continues until nothing permanent is left behind.

OSSIOfiber^® is currently commercially available in the US. If you are interested in using OSSIOfiber^®, please fill out the form below and a team member will be in touch.